HF Advisory Group Boosts Cardinal Health Stake by 97.5%

Got story updates? Submit your updates here. ›

HF Advisory Group LLC, an investment management firm, significantly increased its stake in Cardinal Health, Inc. (NYSE: CAH) during the fourth quarter of 2025. The firm added 5,049 shares, boosting its total holdings in the pharmaceutical distribution company by 97.5% to 10,227 shares worth $2.1 million.

Why it matters

Cardinal Health is one of the largest pharmaceutical and medical supply distributors in the United States, serving hospitals, pharmacies, and other healthcare providers. The increase in HF Advisory Group's position suggests the firm sees growth potential in Cardinal Health's business amid ongoing industry trends like the rise of specialty pharmaceuticals and the shift to value-based care.

The details

According to a recent 13F filing with the Securities and Exchange Commission, HF Advisory Group purchased an additional 5,049 shares of Cardinal Health stock during the fourth quarter of 2025. This increased the firm's total position to 10,227 shares, up from 5,178 shares held at the end of the prior quarter. The increased stake is now valued at $2.1 million based on Cardinal Health's closing stock price on March 31, 2026.

• HF Advisory Group filed its 13F report for the fourth quarter of 2025 on April 2, 2026.
• The firm increased its Cardinal Health holdings during the three-month period ending December 31, 2025.

What’s next

Investors will be watching to see if other institutional investors follow HF Advisory Group's lead and increase their stakes in Cardinal Health in the coming quarters.